--- title: 'Quality Control Technician – RNA, LNPs & DNA at Artis BioSolutions' canonical: 'https://feeny.ai/job/quality-control-technician-rna-lnps-dna-artis-biosolutions-bilbao-3smyhxp98qj1' type: 'job' last_seen: '2026-10-29' --- # Quality Control Technician – RNA, LNPs & DNA at Artis BioSolutions - **Company:** Artis BioSolutions - **Location:** Bilbao, Spain - **Employment:** full-time - **Work type:** onsite - **Posted:** 2026-10-20 - **Last confirmed live:** 2026-10-29 - **Apply:** https://jobs.lever.co/landmarkbio/69cb40ec-54a1-416a-be1a-41ae3e45d302 ## Job description Artis BioSolutions Nucleic Acids Center of Excellence in Bilbao is dedicated to the development and manufacturing of advanced nucleic acid-based products, including RNA, lipid nanoparticles (LNPs) and DNA technologies. We are looking for a Quality Control Technician to join our team in Bilbao, Spain, supporting the development, implementation and execution of analytical methods for the quality control of RNA, lipid nanoparticles (LNPs) and DNA in a GMP-regulated environment. The position will be involved in analytical method development, qualification, verification and validation, as well as routine GMP testing and batch release activities. ## RESPONSIBILITIES - Perform analytical testing for the characterization and quality control of RNA, LNPs and DNA. - Support analytical method development, implementation, qualification, verification, validation and transfer. - Plan analytical testing and experimental activities, coordinating day-to-day laboratory work with QC Analysts. - Provide technical guidance to QC Analysts and review analytical results and documentation. - Prepare and update SOPs, analytical procedures, protocols and reports. - Review and document analytical data in accordance with GMP and data integrity requirements. - Support OOS/OOT investigations and analytical troubleshooting. ## PROFILE - Degree in Biotechnology, Chemistry, Pharmacy, Biochemistry, Biology or a related scientific discipline. - Minimum 2 years of laboratory experience, preferably in a pharmaceutical, biotechnology or GMP environment. - Experience in Quality Control, nucleic acid analysis, analytical method development/validation or analytical transfer will be highly valued. - Knowledge of GMP, data integrity and ALCOA+ principles. - English B2 or above, with the ability to communicate effectively in a technical and GMP-regulated environment. Hands-on experience in one or more of the following techniques will be highly valued: - Capillary electrophoresis and agarose gel electrophoresis - HPLC/UHPLC and LC-MS - qPCR and ddPCR - UV-Vis spectrophotometry and fluorescence-based assays - Dynamic Light Scattering (DLS) and other nanoparticle characterization techniques - ELISA and immunoblotting - Sequencing and sequence data interpretation - Microbiological testing Experience applying these techniques to the characterization and quality control of RNA, DNA and/or LNPs-based products will be particularly valued. ## WHAT WE OFFER - Permanent, full-time position based in Bilbao. - Opportunity to work with advanced RNA, LNPs and DNA technologies in a GMP environment. - Direct involvement in the development and implementation of new analytical capabilities. - Professional development opportunities within a growing biotechnology company. - Competitive salary based on experience. ## About Artis BioSolutions ## Company Overview - **One-liner**: Artis BioSolutions is an integrated platform for synthetic DNA production and advanced therapy manufacturing, accelerating genetic medicines from discovery through commercial GMP production. - **Entity Type**: Private (backed by Oak HC/FT; acquired Landmark Bio in 2025) - **Headquarters**: Carlsbad, California, United States (also operations in Watertown, MA and Bilbao, Spain) - **Founded**: 2024 - **Founders**: Brian Neel (CEO) and Michael Houston (Co-Founder & CSO) ## Core Business - **Primary industry**: Contract Development and Manufacturing Organization (CDMO) for genetic medicines; biotechnology - **Target customers**: Biopharma companies developing mRNA therapies, gene editing, viral vectors, cell therapies (CAR-T, CAR-NK, iPSCs), vaccines, and emerging modalities - **Mission**: To advance genetic medicines and biologics from early development to market by replacing fragmented supply chains with an integrated, synthetic DNA-powered platform. ## Products & Services - **Synthetic DNA (oDNA)**: Proprietary enzymatic manufacturing of truly synthetic, plasmid-free DNA at RUO and GMP grades, delivered in 2 weeks (RUO) or 3-4 weeks (GMP) up to gram scale. - **Cell Therapies**: Autologous and allogeneic cell therapy development and manufacturing, including CAR-T, CAR-NK, iPSCs, MSCs, and organoids. - **Viral Vectors**: AAV and lentiviral vector production from research scale through GMP. - **mRNA and LNP**: In vitro transcription, formulation, and translational development. - **Emerging Modalities**: Support for extracellular vesicles, non-viral delivery platforms, and novel technologies. - **Integrated Services**: CMC strategy, regulatory support, process and formulation development, analytical development, GMP manufacturing, and fill/finish. ## Market Standing - **Valuation/Market Cap**: Not disclosed (private) - **Key Metric**: Total funding undisclosed; backed by Oak HC/FT; acquired Landmark Bio in 2025 for an undisclosed sum. - **Notable Investors/Partners**: Oak HC/FT (lead venture and growth equity firm) - **Growth Signals**: - Emerged from stealth in April 2025 with acquisition of Landmark Bio (~75 employees). - Combined headcount ~80 employees (as of early 2025), with LinkedIn showing +80% YoY growth. - Dual manufacturing sites in the US (Watertown, MA) and EU (Bilbao, Spain). - 2-week RUO synthetic DNA production timeline – significantly faster than industry standard. ## Competitive Advantages - **Integrated platform** that replaces fragmented supply chains – one vendor from synthetic DNA through GMP fill/finish. - **Proprietary enzymatic oDNA** eliminates plasmid dependency, reducing contamination risk and accelerating timelines. - **Multi-modality capability** (mRNA, viral vectors, cell therapies, emerging) from a single infrastructure. - **US and EU GMP manufacturing** enables global supply chain resilience. - **Flexible engagement models** from defined-scope projects to deep co-development partnerships. ## Strategic Focus - Build a portfolio of subsidiaries (starting with Landmark Bio) to create a single-source CDMO for complex genetic medicines. - Reduce project timelines and manufacturing costs for customers while maintaining quality. - Pursue additional strategic acquisitions in partnership with Oak HC/FT to expand capabilities and respond to market shifts (e.g., mRNA, gene editing). - Scale enzymatic synthetic DNA production as a foundational technology for all genetic medicine modalities. ## Why Work Here - **Mission-driven environment**: Directly contribute to bringing life-changing genetic therapies to patients faster. - **Rapid growth**: Company emerged from stealth in 2025 and is actively scaling – potential for career advancement. - **Geographic options**: Opportunities at the Carlsbad, CA headquarters, Watertown, MA (Landmark Bio site), and Bilbao, Spain. - **Cutting-edge technology** – work with synthetic DNA, mRNA, viral vectors, cell therapy – not just a traditional CDMO. - **Backed by top-tier investors** (Oak HC/FT) providing stability and long-term vision. - **Culture highlights**: Small, agile team with strong scientific leadership; collaborative approach with clients; emphasis on quality and innovation. - **Perks**: Not explicitly listed, but as a biotech CDMO, likely includes standard benefits, potential equity, and opportunities to work on groundbreaking therapies. ## Sources 1. [Artis BioSolutions Official Website](https://artisbiosolutions.com) 2. [Artis BioSolutions LinkedIn](https://linkedin.com/company/artis-biosolutions) 3. [Artis BioSolutions Leadership Page (Landmark Bio)](https://landmarkbio.com/staff-category/artis-biosolutions-leadership-team/) 4. [San Diego Business Journal – Artis BioSolutions Emerges from Stealth](https://sdbj.com/life-sciences/artis-biosolutions-emerges-from-stealth-with-acquisition/) ## Other roles at Artis BioSolutions - [Associate Director, Commercial Technical Solutions](https://feeny.ai/job/associate-director-commercial-technical-solutions-artis-biosolutions-watertown-hwts86wse0sq) — Watertown, MA - [Supply Chain Technician](https://feeny.ai/job/supply-chain-technician-artis-biosolutions-bilbao-g89h5q18h4rs) — Bilbao, Spain - [Production Technician](https://feeny.ai/job/production-technician-artis-biosolutions-bilbao-abee6z6vx60c) — Bilbao, Spain - [Production Operator](https://feeny.ai/job/production-operator-artis-biosolutions-bilbao-bfzf8w6xsfv0) — Bilbao, Spain - [Associate Scientist, Analytics](https://feeny.ai/job/associate-scientist-analytics-artis-biosolutions-watertown-ksxbtxx8q321) — Watertown, MA - [Downstream Associate Scientist (Contract 3 to 6 months)](https://feeny.ai/job/downstream-associate-scientist-contract-3-to-6-months-artis-biosolutions-kcygep0skae3) — Watertown, MA - [Associate Director, Quality Systems](https://feeny.ai/job/associate-director-quality-systems-artis-biosolutions-watertown-bvw59taspn0w) — Watertown, MA - [Manager, Environmental Health & Safety (EHS)](https://feeny.ai/job/manager-environmental-health-safety-ehs-artis-biosolutions-watertown-chqjw596f5p4) — Watertown, MA